Medical Decisions in the Hospital Setting- M-Safety

Sponsor
University of Michigan (Other)
Overall Status
Completed
CT.gov ID
NCT03757884
Collaborator
Agency for Healthcare Research and Quality (AHRQ) (U.S. Fed)
59
2
1
12.2
29.5
2.4

Study Details

Study Description

Brief Summary

This project will introduce and evaluate an intervention designed to improve diagnostic decision making. The intervention will attempt to increase clinician mindfulness and reduce environmental distractions to promote focused thinking. A meta-cognitive intervention using a structured checklist will be evaluated to identify improvement in diagnostic and therapeutic decision-making and examine the role of mindfulness and architectural design in enhancing patient safety.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Mindfulness breathing exercise
  • Behavioral: Diagnostic Checklist
  • Behavioral: Noise cancelling headphones
  • Behavioral: Privacy tablescreen
  • Behavioral: Diagnostic assistance application
N/A

Detailed Description

This project will introduce and evaluate an intervention designed to improve diagnostic decision making. The intervention will attempt to increase clinician mindfulness and reduce environmental distractions to promote system 2 thinking. A meta-cognitive intervention using a structured checklist will be evaluated to identify improvement in diagnostic and therapeutic decision-making and examine the role of mindfulness and architectural design in enhancing patient safety.

This a pretest-posttest design study that will be conducted with hospitalist physicians working at Michigan Medicine and/or the VA Ann Arbor Healthcare System. The proposed intervention will provide the participants with tools to help promote mindfulness and focus to assist with the diagnostic process. To reduce distraction, headphones to block out surrounding noise and table screens to limit distractions will be offered. To assist with diagnosis, a diagnostic checklist and use of a IPad to use an online diagnosis application will be provided.

Study Design

Study Type:
Interventional
Actual Enrollment :
59 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Pre-posttest study designPre-posttest study design
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Improving Medical-Decision Through Cognition, Technology and Communication, Phase 2
Actual Study Start Date :
Sep 10, 2018
Actual Primary Completion Date :
Sep 17, 2019
Actual Study Completion Date :
Sep 17, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Virtual Pod

Mindfulness breathing, privacy screen, noise cancelling headphones, diagnostic checklist, diagnostic support on-line application

Behavioral: Mindfulness breathing exercise
Spire monitor instructed mindfulness breathing

Behavioral: Diagnostic Checklist
Checklist reminder for diagnosis

Behavioral: Noise cancelling headphones
Noise cancelling headphones

Behavioral: Privacy tablescreen
Privacy Tablescreen

Behavioral: Diagnostic assistance application
Diagnostic assistance application

Outcome Measures

Primary Outcome Measures

  1. Change in Number of Patient Differential Diagnosis [8 months]

    Differential Diagnosis

  2. Change in the Use of Diagnostic Checklist [8 months]

    Diagnostic Checklist

Secondary Outcome Measures

  1. Change in Mindfulness Behaviors Score [8 months]

    This 4 Question Survey Measures Characteristics of Mindfulness, Range- 1=Always, 6=Never

  2. Change in Number of Patient Diagnostic Testing [8 months]

    Diagnostic Testing includes Laboratory and Imaging

  3. Change in Time Participants are Measured as Calm [8 months]

    Time Measured in Minutes, Using the Spire Monitor

  4. Change in Time Participants are Measured as Focused [8 months]

    Time Measured in Minutes, Using the Spire Monitor

  5. Change in Time Participants are Measured as Tense [8 months]

    Time Measured in Minutes, Using the Spire Monitor

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 99 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Hospital Medicine Physicians
Exclusion Criteria:
  • Physicians other than Hopitalists

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ann Arbor VA Healthcare System Ann Arbor Michigan United States 48105
2 University of Michigan Ann Arbor Michigan United States 48109

Sponsors and Collaborators

  • University of Michigan
  • Agency for Healthcare Research and Quality (AHRQ)

Investigators

  • Principal Investigator: Vineet I Chopra, MD, University of Michigan

Study Documents (Full-Text)

More Information

Additional Information:

Publications

Responsible Party:
Vineet Chopra, Chief, Division of Hospital Medicine, University of Michigan
ClinicalTrials.gov Identifier:
NCT03757884
Other Study ID Numbers:
  • HUM00145793
First Posted:
Nov 29, 2018
Last Update Posted:
Sep 20, 2019
Last Verified:
Sep 1, 2019
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Vineet Chopra, Chief, Division of Hospital Medicine, University of Michigan

Study Results

No Results Posted as of Sep 20, 2019